Study: NCT02839668

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Continuous infusion of lidocaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Continuous infusion of lidocaine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: maintenance of hypnosis during anaesthesia with sevoflurane

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: maintenance of hypnosis during anaesthesia with sevoflurane

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TIVA-TCI
Description: maintenance of hypnosis during anaesthesia with sevoflurane

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TIVA-TCI
Description: maintenance of hypnosis during anaesthesia with sevoflurane

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: administration of 1 g acetaminophen for postoperative analgesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: administration of 1 g acetaminophen for postoperative analgesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: administration of 1 g acetaminophen for postoperative analgesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: administration of 1 g acetaminophen for postoperative analgesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: administration of tramadol for postoperative analgesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: administration of tramadol for postoperative analgesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: administration of tramadol for postoperative analgesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: administration of tramadol for postoperative analgesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine
Description: A 0.05 mg/kg dose of neostigmine will be administered to antagonize the neuromuscular block at the end of surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: A 0.05 mg/kg dose of neostigmine will be administered to antagonize the neuromuscular block at the end of surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine
Description: A 0.05 mg/kg dose of neostigmine will be administered to antagonize the neuromuscular block at the end of surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: A 0.05 mg/kg dose of neostigmine will be administered to antagonize the neuromuscular block at the end of surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine
Description: A 0.2 mg/kg dose of atropine will be administered at the end of surgery to attenuate the parasymatomimetic effects of neostigmine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atropine
Description: A 0.2 mg/kg dose of atropine will be administered at the end of surgery to attenuate the parasymatomimetic effects of neostigmine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine
Description: A 0.2 mg/kg dose of atropine will be administered at the end of surgery to attenuate the parasymatomimetic effects of neostigmine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atropine
Description: A 0.2 mg/kg dose of atropine will be administered at the end of surgery to attenuate the parasymatomimetic effects of neostigmine

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIS
Description: For the groups receveing TIVA-TCI anesthesia the bispectral index will be monitored

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BIS
Description: For the groups receveing TIVA-TCI anesthesia the bispectral index will be monitored

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIS
Description: For the groups receveing TIVA-TCI anesthesia the bispectral index will be monitored

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BIS
Description: For the groups receveing TIVA-TCI anesthesia the bispectral index will be monitored